Up-regulation of P-glycoprotein by HIV protease inhibitors in a human brain microvessel endothelial cell line.
about
Multifunctional nanoparticles for brain tumor imaging and therapy.Drug transporters in tissues and cells relevant to sexual transmission of HIV: Implications for drug deliveryInhibition of P-glycoprotein by HIV protease inhibitors increases intracellular accumulation of berberine in murine and human macrophagesSpecific increase in MDR1 mediated drug-efflux in human brain endothelial cells following co-exposure to HIV-1 and saquinavirInduction of P-glycoprotein and Bcrp at the rat blood-brain barrier following a subchronic morphine treatment is mediated through NMDA/COX-2 activationBrain dysfunction in the era of combination antiretroviral therapy: implications for the treatment of the aging population of HIV-infected individualsRegulation of P-glycoprotein by human immunodeficiency virus-1 in primary cultures of human fetal astrocytes.Concentration-dependent effects and intracellular accumulation of HIV protease inhibitors in cultured CD4 T cells and primary human lymphocytes.Penetration of drugs through the blood-cerebrospinal fluid/blood-brain barrier for treatment of central nervous system infections.Intact lipid rafts regulate HIV-1 Tat protein-induced activation of the Rho signaling and upregulation of P-glycoprotein in brain endothelial cellsLocalization microscopy (SPDM) reveals clustered formations of P-glycoprotein in a human blood-brain barrier modelExposure to HIV-protease inhibitors selects for increased expression of P-glycoprotein (ABCB1) in Kaposi's sarcoma cells.Raltegravir permeability across blood-tissue barriers and the potential role of drug efflux transporters.Eradication of HIV-1 from the macrophage reservoir: an uncertain goal?Editorial neuroAIDS review.Pregnane X receptor regulates drug metabolism and transport in the vasculature and protects from oxidative stress.Targeting blood-brain barrier changes during inflammatory pain: an opportunity for optimizing CNS drug delivery.Inflammatory cell trafficking across the blood-brain barrier: chemokine regulation and in vitro models.Regulation of ABC efflux transporters at blood-brain barrier in health and neurological disorders.1α,25-Dihydroxyvitamin D3-liganded vitamin D receptor increases expression and transport activity of P-glycoprotein in isolated rat brain capillaries and human and rat brain microvessel endothelial cellsSensitivity of intravenous and oral alfentanil and pupillary miosis as minimal and noninvasive probes for hepatic and first-pass CYP3A induction.Microglial activation decreases retention of the protease inhibitor saquinavir: implications for HIV treatment.HIV-1 Alters Intestinal Expression of Drug Transporters and Metabolic Enzymes: Implications for Antiretroviral Drug DispositionAntiretroviral drug transporters and metabolic enzymes in human testicular tissue: potential contribution to HIV-1 sanctuary site.Influence of drug transport proteins on the pharmacokinetics and drug interactions of HIV protease inhibitors.Induction of P-glycoprotein by antiretroviral drugs in human brain microvessel endothelial cells.Acetaminophen modulates P-glycoprotein functional expression at the blood-brain barrier by a constitutive androstane receptor-dependent mechanismHomodimers of the Antiviral Abacavir as Modulators of P-glycoprotein Transport in Cell Culture: Probing Tether Length.Drug interactions at the blood-brain barrier: fact or fantasy?Immortalized human brain endothelial cell line HCMEC/D3 as a model of the blood-brain barrier facilitates in vitro studies of central nervous system infection by Cryptococcus neoformans.Transforming growth factor-beta signaling alters substrate permeability and tight junction protein expression at the blood-brain barrier during inflammatory painRole of P-glycoprotein in the distribution of the HIV protease inhibitor atazanavir in the brain and male genital tract.Specific microbicides in the prevention of HIV infection.Efflux pump-mediated resistance in chemotherapy.The hCMEC/D3 cell line as a model of the human blood brain barrier.Effect of quercetin on the transport of ritonavir to the central nervous system in vitro and in vivo.Drug transporter gene expression in human colorectal tissue and cell lines: modulation with antiretrovirals for microbicide optimization.Marked differences in the effect of antiepileptic and cytostatic drugs on the functionality of P-glycoprotein in human and rat brain capillary endothelial cell lines.Role of drug efflux and uptake transporters in atazanavir intestinal permeability and drug-drug interactions.Quantitative fluorescence microscopy provides high resolution imaging of passive diffusion and P-gp mediated efflux at the in vivo blood-brain barrier.
P2860
Q26865418-D2439A72-926B-4948-86DF-58EE28B08AFBQ28081272-94EB14EB-C185-405F-A088-812F33B54D98Q28485263-858985D0-BA9E-4E87-9E0E-7A5748050EFEQ28534049-289C8B84-8CCA-465F-ACE5-22CF681D6B9AQ28578377-960C2399-4B86-42E2-B333-BDDED82CA6D8Q33614467-C02DAE48-09E5-4477-A7D9-7763FC133710Q33684254-9BE267C2-0DB6-4E90-9292-88712A8D0E9BQ33776536-2D72DEB1-8075-4CED-9438-26BFD5F10E65Q34142328-CB4634C0-C8B3-4544-866F-218B69D5DD16Q34170914-1D8D3FAE-142F-4061-A73B-C7CEA7B43D14Q34416094-274179F1-4C86-4717-B903-2429C1D88BB6Q35208091-DBCCB65D-09C6-4DF6-9BF9-82DDED19F5F2Q35385630-F9AEFB6E-BDE1-42DF-A2EA-3F531890D13FQ35544355-EFD4FF71-9F58-4D40-8DF9-14FC1E914F1BQ35731648-67E4451C-1C53-48C6-81DF-011C4BA6FE98Q35792726-B55B395F-1061-4570-88F8-469C65D1CC21Q35855634-52D2A132-65B1-45ED-8B0E-5A0F90E3E2D6Q36059965-8D8D4E83-F703-4F4B-9AA2-10B0C8F97563Q36378047-CDBA1883-B571-4336-AA39-B701F2A577F5Q36512766-CD2FC344-68C8-4FDE-873B-BF3708DE14B0Q36578060-7C71E9FD-3594-4E22-96C6-A85DA5A85194Q36835199-C85773FB-3A3F-48C7-B541-1BA3FBAA395FQ36888037-DA3E97BC-2DE7-4818-8AB1-376E4B071826Q36977376-59FA0CAF-1C25-4980-9A68-246EC7ABB7C9Q37113947-4FE477E7-4051-4956-88CE-EEBC087DA373Q37124197-5AFE74FE-957D-4626-9F01-0EA1B8D0AE85Q37252086-4141D182-6299-4176-8146-3B871714EE4FQ37323391-B6D700E0-36C2-44E7-A0C3-1208A5F20B4DQ37362486-5FBFA9F9-BBBF-4A73-B91D-6F53B5C7BD03Q37410097-E082040F-40D1-432E-8852-96066BDCC756Q37543496-148026DE-69E4-4293-8D5E-48CA75450D5CQ37643618-575E1698-FBE7-4F69-B5BD-BC65B1CF2B8AQ37932048-82D43134-DF10-4383-BBE2-7D2186B425BBQ38084554-0407D91C-A6E4-4C28-AEAA-553FD52B69C5Q38093329-D1555DB1-3A11-4BE8-A5A2-76BA86B4F3C8Q38787647-0EC63082-47B6-4E55-B635-C2664A02CD80Q38823939-F545AC0A-630B-4C21-9A49-01C4F0BB3494Q39029172-7B93B42C-EC11-47D9-92AC-678D9AEC8D30Q39229674-10D200E0-2577-4362-AF03-60BD16E25ED0Q39372353-3C7FC6C9-3344-481E-8D29-476DD84211F1
P2860
Up-regulation of P-glycoprotein by HIV protease inhibitors in a human brain microvessel endothelial cell line.
description
2009 nî lūn-bûn
@nan
2009 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի մարտին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Up-regulation of P-glycoprotei ...... ovessel endothelial cell line.
@ast
Up-regulation of P-glycoprotei ...... ovessel endothelial cell line.
@en
type
label
Up-regulation of P-glycoprotei ...... ovessel endothelial cell line.
@ast
Up-regulation of P-glycoprotei ...... ovessel endothelial cell line.
@en
prefLabel
Up-regulation of P-glycoprotei ...... ovessel endothelial cell line.
@ast
Up-regulation of P-glycoprotei ...... ovessel endothelial cell line.
@en
P2093
P356
P1476
Up-regulation of P-glycoprotei ...... ovessel endothelial cell line.
@en
P2093
Babette Weksler
Gary N Y Chan
Jason A Zastre
Manisha Ramaswamy
Moise Bendayan
Patrick T Ronaldson
Pierre O Couraud
Reina Bendayan
P2860
P304
P356
10.1002/JNR.21898
P577
2009-03-01T00:00:00Z